103 related articles for article (PubMed ID: 6146333)
21. The effects of pretreatment with 7,8-benzoflavone on drug-metabolizing enzymes and diethylstilboestrol metabolism in male hamster liver microsomal preparations.
Blaich G; Metzler M
Xenobiotica; 1988 Feb; 18(2):199-206. PubMed ID: 3259760
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of inhibition of microsomal drug metabolism by imidazole.
Hajek KK; Cook NI; Novak RF
J Pharmacol Exp Ther; 1982 Oct; 223(1):97-104. PubMed ID: 7120133
[No Abstract] [Full Text] [Related]
23. Comparison of the effects of various flavonoids on ethoxycoumarin deethylase activity of rat intestinal and hepatic microsomes.
Vernet A; Siess MH
Food Chem Toxicol; 1986 Aug; 24(8):857-61. PubMed ID: 3491024
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of purified lysosomal phospholipase A1 by beta-adrenoceptor blockers.
Pappu AS; Yazaki PJ; Hostetler KY
Biochem Pharmacol; 1985 Feb; 34(4):521-4. PubMed ID: 2857566
[TBL] [Abstract][Full Text] [Related]
25. Single-dose kinetics of oral propranolol, metoprolol, atenolol, and sotalol: relation to lipophilicity.
Ochs HR; Greenblatt DJ; Arendt RM; Schäfer-Korting M; Mutschler E
Arzneimittelforschung; 1985; 35(10):1580-2. PubMed ID: 2866772
[TBL] [Abstract][Full Text] [Related]
26. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol.
Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Miwa S; Muramatsu I
Life Sci; 2007 Jul; 81(5):399-404. PubMed ID: 17628611
[TBL] [Abstract][Full Text] [Related]
27. Induction of disopyramide N-dealkylation by phenobarbital and disopyramide in rat liver.
Aitio ML; Aitio A
Arch Int Pharmacodyn Ther; 1979 May; 239(1):16-23. PubMed ID: 485713
[TBL] [Abstract][Full Text] [Related]
28. Effect of phenobarbital on the distribution of drug metabolizing enzymes between periportal and perivenous rat hepatocytes prepared by digitonin-collagenase liver perfusion.
Bengtsson G; Julkunen A; Penttilä KE; Lindros KO
J Pharmacol Exp Ther; 1987 Feb; 240(2):663-7. PubMed ID: 3027320
[TBL] [Abstract][Full Text] [Related]
29. Effect of hyperthyroidism on the in vitro metabolism and covalent binding of 1,1-dichloroethylene in rat liver microsomes.
Gunasena GH; Kanz MF
J Toxicol Environ Health; 1997 Oct; 52(2):169-88. PubMed ID: 9310148
[TBL] [Abstract][Full Text] [Related]
30. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties.
Austin RP; Barton P; Cockroft SL; Wenlock MC; Riley RJ
Drug Metab Dispos; 2002 Dec; 30(12):1497-503. PubMed ID: 12433825
[TBL] [Abstract][Full Text] [Related]
31. The role of lipophilicity in the inhibition of polymorphic cytochrome P450IID6 oxidation by beta-blocking agents in vitro.
Ferrari S; Leemann T; Dayer P
Life Sci; 1991; 48(23):2259-65. PubMed ID: 1675413
[TBL] [Abstract][Full Text] [Related]
32. The action of beta-adrenoceptor antagonists on rat heart mitochondrial function in vitro: a comparison of propranolol, timolol, and atenolol.
Quinn PJ; Crutcher EC
Cardiovasc Res; 1984 Apr; 18(4):212-9. PubMed ID: 6713449
[TBL] [Abstract][Full Text] [Related]
33. Drug-induced inhibition of guinea pig platelet aggregation unrelated to their beta-adrenolytic actions.
Iwamura M; Ishimori T; Makino M; Yasuda K; Izumi A; Himori N
Jpn J Pharmacol; 1983 Feb; 33(1):219-26. PubMed ID: 6135813
[TBL] [Abstract][Full Text] [Related]
34. The effect of age on pathways of drug metabolism in human liver.
Woodhouse KW; Mutch E; Williams FM; Rawlins MD; James OF
Age Ageing; 1984 Nov; 13(6):328-34. PubMed ID: 6334986
[TBL] [Abstract][Full Text] [Related]
35. In vitro effects of straight-chain alkanes (n-hexane through n-dodecane) on rat liver and lung cytochrome P-450.
Rabovsky J; Judy DJ; Pailes WH
J Toxicol Environ Health; 1986; 18(3):409-21. PubMed ID: 3486981
[TBL] [Abstract][Full Text] [Related]
36. Neonatal testosterone imprinting of hepatic microsomal drug metabolism and a male-specific form of cytochrome P-450 in the rat.
Kamataki T; Maeda K; Shimada M; Nagai T; Kato R
J Biochem; 1984 Dec; 96(6):1939-42. PubMed ID: 6335714
[TBL] [Abstract][Full Text] [Related]
37. Failure of 'therapeutic' doses of beta-adrenoceptor antagonists to alter the disposition of tolbutamide and lignocaine.
Miners JO; Wing LM; Lillywhite KJ; Smith KJ
Br J Clin Pharmacol; 1984 Dec; 18(6):853-60. PubMed ID: 6152176
[TBL] [Abstract][Full Text] [Related]
38. Lipophilic beta-blockers inhibit rat skeletal muscle mitochondrial respiration.
Dreisbach AW; Greif RL; Lorenzo BJ; Reidenberg MM
Pharmacology; 1993 Nov; 47(5):295-9. PubMed ID: 7903463
[TBL] [Abstract][Full Text] [Related]
39. Liquid chromatographic retention of beta-adrenoceptor antagonists: an index of lipid solubility.
Arendt RM; Greenblatt DJ
J Pharm Pharmacol; 1984 Jun; 36(6):400-1. PubMed ID: 6146673
[TBL] [Abstract][Full Text] [Related]
40. The interaction between H2-receptor antagonists and beta-adrenoceptor blockers.
Mutschler E; Spahn H; Kirch W
Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):51S-57S. PubMed ID: 6146340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
